Cargill: FDA phytosterol CHD claim change will cause “irreparable injury”
Industry is calling on the FDA to extend the compliance period to proposed changes the agency is making for a phytosterol-based coronary heart disease (CHD)-lowering health claim that will broaden it beyond esterified forms to include free sterol and...